Single Arm on the Tolerability of Weekly Nab-paclitaxel

NCT01702844 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer (NSCLC)

Interventions

DRUG: Nab-Paclitaxel

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]